• AI Tool Adding Speed and Diversity to Cleveland Clinic Trials

    Clinical Research News | At Cleveland Clinic, a “medically trained” AI system is patient-finding for clinical trials, eliminating the tedium of manual chart reviews for sponsors and investigators requesting digital assistance. Synapsis AI, a Dyania Health technology, was vetted for the job and initially deployed at Cleveland Clinic’s Taussig Cancer Center and its Heart, Vascular and Thoracic Institute.

    Apr 8, 2026

  • Managing Metastatic Cancer: A Matter of Degree

    Clinical Research News | Cancer recurrence is a significant health issue and a major concern for survivors but could potentially be transformed into a manageable chronic condition with the advent of a magnetic nanoparticle hyperthermia system developed by the Israeli startup New Phase and newly installed at the Mayo Clinic last December. The novel technology uses iron oxide-containing nanoparticles that amass in tumors, which are then heated by an electromagnetic field to destroy them.

    Apr 7, 2026

  • Continuous Clinical Trials: History, Hype, and How to Make Them Work

    Clinical Research News | Food and Drug Administration Commissioner Marty Makary has been signaling a potential change to how clinical trials are conducted. Since assuming the Commissioner role, he has championed "continuous trials"  to accelerate drug development, calling the current phased approach inefficient.

    Apr 3, 2026

  • piRNA Blood Test Opens New Pathways for Longevity

    Clinical Research News | A simple blood test built on a handful of small RNA molecules could reshape how researchers study aging and predict survival. Led by Virginia Byers Kraus, M.D. Ph.D., professor in the departments of medicine, pathology, and orthopedic surgery at Duke University School of Medicine, a team of researchers identified piwi-interacting RNAs (piRNAs) as powerful and potentially causal predictors of mortality in older adults.

    Mar 31, 2026

  • Blood Biomarker “Clock” Detects Alzheimer’s Symptoms

    Clinical Research News | Researchers from the Foundation for the National Institutes of Health, Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and other collaborators found that a plasma biomarker—the ratio of phosphorylated to non-phosphorylated plasma tau at position 217, written %p-tau217—can be used to construct a “clock model” that can predict when Alzheimer’s disease symptoms appear.

    Mar 26, 2026

  • Follow the Money: Brain-Computer Retinal Implant Trial Results, Alzheimer’s Platform Development, More

    Clinical Research News | Science Corporation’s PRIMA trial results are featured in The New England Journal of Medicine and on the cover of Time; Cognito Therapeutics continues to clinically develop their Spectris platform; and more.

    Mar 25, 2026

  • Verily, Samsung Partnership, Scite MCP Improves AI Trustworthiness, Johnson & Johnson Receives FDA Approval

    Clinical Research News | Verily Life Sciences and Samsung Electronics America enter a collaboration; Research Solutions launches Scite MCP; Johnson & Johnson receives approval from FDA for TECVAYLI and DARZALEX FASPRO; and more.

    Mar 24, 2026